Evaluate the Efficacy and Safety of Oral Hydroxychloroquine, Indomethacin and Zithromax in Subjects With Mild Symptoms of COVID-19
Condition: COVID-19 Interventions: Drug: Hydroxychloroquine; Drug: Indomethacin; Drug: Zithromax Oral Product Sponsors: Perseverance Research Center, LLC; Athena Medical Group Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 14, 2020 Category: Research Source Type: clinical trials
Evaluate the Efficacy and Safety of Oral Hydroxychloroquine, Indomethacin and Zithromax in Subjects With Mild Symptoms of COVID-19
Condition: COVID-19 Interventions: Drug: Hydroxychloroquine; Drug: Indomethacin; Drug: Zithromax Oral Product Sponsors: Perseverance Research Center, LLC; Athena Medical Group Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 14, 2020 Category: Research Source Type: clinical trials
Evaluate the Efficacy and Safety of Oral Hydroxychloroquine, Indomethacin and Zithromax in Subjects With Mild Symptoms of COVID-19
Condition: COVID-19 Interventions: Drug: Hydroxychloroquine; Drug: Indomethacin; Drug: Zithromax Oral Product Sponsors: Perseverance Research Center, LLC; Athena Medical Group Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 14, 2020 Category: Research Source Type: clinical trials
Combination of Rectal Indomethacin and Pancreatic Duct Stenting Versus Indomethacin Alone in Preventing PEP
Condition: Healthy Intervention: Device: Pancreatic duct stenting Sponsor: Fourth Military Medical University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 9, 2020 Category: Research Source Type: clinical trials